8-K: IDEX Corp Reports Record Q3 Results, Raises Full-Year Guidance

IDEX Corporation announced record third-quarter results with sales up 8% and adjusted diluted EPS up 15%, leading to an increase in full-year financial guidance.

Summary

• IDEX Corporation reported record third-quarter results for the period ended September 30, 2026.
• Record sales reached $952 million, an 8% increase year-over-year on both reported and organic bases.
• Reported diluted Earnings Per Share (EPS) was $1.95, and record adjusted diluted EPS was $1.33, both up 15%.
• Orders for the quarter were $991 million, a 13% increase on both reported and organic bases.
• The company is increasing its full-year financial guidance, projecting organic sales growth of 6.5% to 6.8% and adjusted diluted EPS between $8.91 and $8.96.
• Strategic acquisitions are gaining momentum, contributing to higher-value applications in advantaged markets.
• Shareholders received $129 million through dividends and share repurchases.
• The Health & Science Technologies segment saw a 14% increase in net sales, driven by AI-driven demand in data centers and semiconductor markets.

Sentiment

Score: 9

Explanation: StockSavvy.ai views this as a very positive report, with record results, strong growth across segments, and an increase in full-year guidance.

Positives

• Record sales of $952 million, an 8% increase year-over-year.
• Record adjusted diluted EPS of $2.33, a 15% increase year-over-year.
• Orders increased by 13% to $991 million.
• Full-year organic sales guidance increased to 6.5%-6.8% from 5%-6%.
• Full-year adjusted diluted EPS guidance increased to $8.91-$8.96.
• Gross margin improved by 60 basis points to 45.1% (45.2% adjusted).
• Net income increased by 16.3% to $144.1 million.
• Free cash flow increased to $214.3 million, with a conversion rate of 124%.

Negatives

• Higher employee-related costs, including variable compensation, impacted Adjusted EBITDA margins in the Health & Science Technologies segment.
• Price/cost headwinds partially offset gross margin increases in the Fluid & Metering Technologies and Fire & Safety/Diversified Products segments.
• Corporate costs increased to $25.5 million from $21.7 million, primarily due to higher employee-related costs.

Risks

• Levels of industrial activity and economic conditions in the U.S. and globally.
• Pricing pressures, including inflation and rising interest rates.
• Competitive factors and levels of capital spending in certain industries.
• Impact of severe weather events, natural disasters, and public health threats.
• Economic and political consequences from terrorist attacks, wars, and global conflicts.
• The company's ability to make acquisitions and integrate/operate acquired businesses profitably.
• Cybersecurity incidents.
• Continued growth of artificial intelligence and related demand changes in AI-driven markets.

Future Outlook

The company is increasing its full-year 2026 financial guidance. Full-year organic sales are projected to increase 6.5% to 6.8% over the prior year, up from previous guidance of 5% to 6%. Full-year adjusted diluted EPS is projected to be between $8.91 and $8.96, up approximately 12% year-over-year at the midpoint, an increase from previous guidance of $8.70 to $8.85.

Management Comments

• "We are pleased to report another strong quarter, with results ahead of our expectations."
• "This quarter, we delivered both record sales and adjusted EPS while expanding margins and booked nearly $1 billion in orders."
• "Advantaged markets and larger acquired businesses are driving this performance, and momentum is broadening across the rest of the portfolio."
• "Our teams continued to execute well as we met our customers increasing demand and drove strong incremental margins on the increased volume."
• "Our ability to drive margin expansion during a period of continued inflation demonstrates the strength of our team and the power of 8020."
• "Additionally, 8020 drives each business toward its full potential and provides the right framework for allocating resources and technologies toward the most attractive opportunities for sustainable value creation across IDEX."
• "We are again increasing our full-year financial guidance due to our strong performance year-to-date, with improved visibility and momentum as we close out 2026."

Industry Context

StockSavvy.ai notes that IDEX's strong performance, particularly in the Health & Science Technologies segment driven by AI-related demand in data centers and semiconductor markets, aligns with broader industry trends of increased investment in advanced technologies and infrastructure. The company's focus on 'advantaged markets' and strategic acquisitions appears to be a successful strategy in a competitive landscape.

Stakeholder Impact

• Shareholders: Benefit from increased earnings per share, potential for continued share price appreciation due to strong performance and raised guidance, and capital returns through dividends and share repurchases ($129 million in Q3).
• Employees: Potential for increased variable compensation due to strong company performance, but also face higher employee-related costs impacting segment margins.
• Customers: Benefit from IDEX's ability to meet increasing demand and provide solutions in critical industries.
• Suppliers: May experience increased demand for materials and services due to higher production volumes.

Next Steps

• Continue to execute on strategic acquisitions and integrate them into higher-value applications.
• Leverage the '80/20' framework for resource allocation and identifying attractive opportunities.
• Focus on driving margin expansion and incremental margins on increased volume.
• Monitor and adapt to macroeconomic challenges, tariffs, and global trade policies.
• Continue to meet increasing customer demand across various end markets.

Key Dates

Recommendation

The filing demonstrates exceptionally strong Q3 performance exceeding expectations, with record sales and EPS. The company is proactively increasing its full-year guidance, indicating robust operational execution and positive market dynamics, particularly in high-growth sectors like AI. Strategic acquisitions are performing well, and capital is being returned to shareholders. This combination of strong current results, positive future outlook, and effective capital allocation warrants a strong buy recommendation.

Keywords

IDEX Corporation, Third Quarter Results, Financial Performance, Organic Sales Growth, Adjusted EPS, Acquisitions, Health & Science Technologies, Fluid & Metering Technologies